Literature DB >> 27251875

Effect of Continuous Positive Airway Pressure on Blood Pressure Variability in Patients With Obstructive Sleep Apnea.

Martino F Pengo1,2,3, Culadeeban Ratneswaran4, Marc Berry4, Brian D Kent4, Malcolm Kohler5, Gian Paolo Rossi6, Joerg Steier4,7.   

Abstract

Obstructive sleep apnea (OSA) is a common risk factor for cardiovascular disease. Continuous positive airway pressure (CPAP) improves OSA symptoms and blood pressure (BP) control. The effect of CPAP on BP variability (BPV) in patients with and without hypertension treated with autotitrating CPAP (APAP) for 2 weeks was studied. A total of 78 participants (76.9% men, 49% hypertensive, mean body mass index 36.2 [6.9] kg/m2 , age 49.0 [12.9] years) underwent 2 weeks of APAP therapy. Office BP, BPV (standard deviation of three BP measurements), and pulse rate were measured before and after treatment. Systolic BPV (5.3±4.9 vs 4.2±3.4 mm Hg, P=.047) and pulse rate (78.0±14.5 vs 75.5±15.8 beats per minute, P=.032) decreased after treatment, particularly in hypertensive participants. Mask leak was independently associated with reduced changes in systolic BPV (r=-0.237, P=.048). Short-term APAP treatment reduced BPV and pulse rate, particularly in hypertensive patients with OSA. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27251875      PMCID: PMC8031566          DOI: 10.1111/jch.12845

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  26 in total

1.  Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study.

Authors:  Jouni K Johansson; Teemu J Niiranen; Pauli J Puukka; Antti M Jula
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

Review 2.  Positive pressure therapy: a perspective on evidence-based outcomes and methods of application.

Authors:  Mark H Sanders; Josep M Montserrat; Ramon Farré; Rachel J Givelber
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

3.  Predicted relative prevalence estimates for obstructive sleep apnoea and the associated healthcare provision across the UK.

Authors:  Joerg Steier; Alistair Martin; Judy Harris; Ian Jarrold; Darien Pugh; Adrian Williams
Journal:  Thorax       Date:  2013-09-23       Impact factor: 9.139

4.  Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea.

Authors:  K Narkiewicz; P J van de Borne; N Montano; M E Dyken; B G Phillips; V K Somers
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

Review 5.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 6.  Pathophysiology of obstructive sleep apnoea.

Authors:  P C Deegan; W T McNicholas
Journal:  Eur Respir J       Date:  1995-07       Impact factor: 16.671

Review 7.  CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis.

Authors:  Daniel J Bratton; Thomas Gaisl; Annette M Wons; Malcolm Kohler
Journal:  JAMA       Date:  2015-12-01       Impact factor: 56.272

8.  Altered cardiovascular variability in obstructive sleep apnea.

Authors:  K Narkiewicz; N Montano; C Cogliati; P J van de Borne; M E Dyken; V K Somers
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

9.  Sympathetic activity in obese subjects with and without obstructive sleep apnea.

Authors:  K Narkiewicz; P J van de Borne; R L Cooley; M E Dyken; V K Somers
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

10.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Peter S Sever; Neil R Poulter
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

View more
  14 in total

1.  Moderate to Severe Obstructive Sleep Apnea in Military Personnel Is Not Associated With Decreased Exercise Capacity.

Authors:  Tyler A Powell; Vincent Mysliwiec; James K Aden; Michael J Morris
Journal:  J Clin Sleep Med       Date:  2019-06-15       Impact factor: 4.062

2.  Metoprolol has a similar therapeutic effect as amlodipine on BP lowering in hypertensive patients with obstructive sleep apnea.

Authors:  Jing Shi; Yue Yuan; Xianzhu Deng; Yujiao Pan; Meijiao He; Guangzhong Liu; Danghui Sun; Jiayu Wang; Wennan Wang; Yue Li
Journal:  Sleep Breath       Date:  2018-06-27       Impact factor: 2.816

3.  Preface for the 3rd Clinical Update Sleep, 23rd February 2018, Royal College of Physicians, London, UK: year in review.

Authors:  Culadeeban Ratneswaran; Manpreet K Sagoo; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 4.  A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease.

Authors:  Jennifer E Dominguez; Ashraf S Habib; Andrew D Krystal
Journal:  Sleep Med Rev       Date:  2018-05-28       Impact factor: 11.609

Review 5.  Cardiorespiratory interaction with continuous positive airway pressure.

Authors:  Martino F Pengo; Sara Bonafini; Cristiano Fava; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

6.  APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure.

Authors:  Jens Spiesshoefer; Julia Aries; Alberto Giannoni; Michele Emdin; Henrik Fox; Matthias Boentert; Thomas Bitter; Olaf Oldenburg
Journal:  Sleep Breath       Date:  2019-06-25       Impact factor: 2.816

Review 7.  Systemic hypertension in obstructive sleep apnea.

Authors:  Carolina Lombardi; Martino F Pengo; Gianfranco Parati
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 8.  Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management.

Authors:  Liann Abu Salman; Rachel Shulman; Jordana B Cohen
Journal:  Curr Cardiol Rep       Date:  2020-01-18       Impact factor: 2.931

9.  Which is the most important factor in the relationship between cardiovascular events and obstructive sleep apnea: Blood pressure level, blood pressure variability or baroreflex sensitivity?

Authors:  Zhenhua Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-10       Impact factor: 3.738

10.  Impact of in-hospital blood pressure variability on cardiovascular outcomes in patients with acute coronary syndrome.

Authors:  Ayman Khairy Mohamed Hassan; Hatem Abd-El Rahman; Kerolos Mohsen; Salwa R Dimitry
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.